Clinical trial
clinical trial
Response-adapted therapy of stage III-IV Hodgkin lymphoma using early interim FDG-PET imaging
Intervention
Radiologic intervention
Intervention Type
radiologic intervention
has_intervention
Fludeoxyglucose F 18
radiologic intervention
Fludeoxyglucose F 18
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Procarbazine hydrochloride
drug intervention
Procarbazine hydrochloride
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Dacarbazine
drug intervention
Dacarbazine
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Vinblastine sulfate
drug intervention
Vinblastine sulfate
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Doxorubicin hydrochloride
drug intervention
Doxorubicin hydrochloride
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Cyclophosphamide
drug intervention
Cyclophosphamide
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Vincristine sulfate
drug intervention
Vincristine sulfate
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Etoposide
drug intervention
Etoposide
Intervention
intervention
planned process
planned process
process
occurrent
entity
Drug intervention
drug intervention
Prednisone
drug intervention
Prednisone
Intervention
intervention
planned process
planned process
process
occurrent
entity
Contact
has contact
has_contact
Berenberg, Jeffrey
PI
has PI
has_PI
Topic
has topic
has_topic
Hodgkin's lymphoma
Funded by
funded by
funded_by
SWOG
Phase
Phase 2 clinical trial
has phase
has_phase
Phase 2
Performed by
human study performed by
human_study_performed_by
Clinical Protocol & Data Management Shared Resource
http://www.clinicaltrials.gov/ct2/show/NCT00822120?term=S0816&rank=2
ClinicalTrials.gov url
ClinicalTrials.gov url
CTurl
Antineoplastic combined chemotherapy protocols
Additional Topic(s)
has_subject_area
RATIONALE: G-CSF may help lessen the side effects in patients receiving chemotherapy. Imaging procedures, such as fludeoxyglucose F 18-PET/CT imaging, may help doctors predict how patients will respond to treatment.
PURPOSE: This phase II trial is studying fludeoxyglucose F 18-PET/CT imaging to see how well it works in assessing response to combination chemotherapy and allow doctors to plan better additional further treatment in treating patients with stage III or stage IV Hodgkin lymphoma.
Resource Description
resource_description
Males and females from ages 18 to 60 years are eligible.
Study Population
study population
has_study_population
2011-06-29T19:18:32.659-05:00
awendicke (Annemarie Wendicke)
2011-09-23T11:28:06.698-05:00
workflow state
Published
nvasilevsky
cpealer
Interventional study
Research project
research project
Human Study
human study
human study
planned process
planned process
Quantitative human study
process
occurrent
entity